The Pharma Data

DECEMBER 14, 2020

FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use. 14, 2020 — The first genetically engineered pigs for use as food or for potential future biomedical use — such as transplantation — in humans have been approved by the U.S. Professional. MONDAY, Dec.

Genetic Engineering 52

Genetic Engineering Engineer FDA Approval Genetics 52

Pharmaceutical Technology

APRIL 5, 2023

It will be six years since the US FDA approval of Kymriah in August this year. Bruce Levine [BL]: We now have six approved CAR-T therapies. That’s not to say that we couldn’t have some approvals coming next year or the year after that for allogeneic therapies. How has the field changed in recent years?

Gene Therapy 147

Gene Therapy Gene Engineer Production 147

Advarra

AUGUST 8, 2023

As of June 2023, 416 Phase III studies are listed, representing a growing pipeline of gene therapy products preparing to undergo consideration for FDA approval. Risks and Regulatory Requirements Most clinical researchers are familiar with the regulatory requirements pertaining to the FDA phases of review as well as with IRB review.

Gene Therapy 52

Gene Therapy Gene Research Genetics 52

The Pharma Data

NOVEMBER 9, 2020

is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs. NVX-CoV2373 (SARS-CoV-2 vaccine) FDA Approval History. Source link.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 30, 2020

is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs. NVX-CoV2373 (SARS-CoV-2 vaccine) FDA Approval History. Source link.

Clinical Development 52

Clinical Development Vaccination Vaccine Development 52

pharmaphorum

NOVEMBER 2, 2021

Clinical interest in bsAbs gained momentum following the promising data and market success of blinatumomab (BLINCYTO®, Amgen), a fragment-based bispecific T cell engager (BiTE), which first received FDA approval in 2014 and EMA approval in 2015.

Antibody 52

Antibody Immune Response Production Engineer 52

XTalks

MARCH 6, 2024

This includes discussions on cutting-edge technologies and methodologies in brain research, such as neuroimaging, genetic engineering and artificial intelligence. Boston Scientific’s Deep Brain Stimulation (DBS) Software received FDA approval last year for the treatment of Parkinson’s disease and essential tremor.

FDA Approval 69

FDA Approval In-Vitro Research Marketing 69